Updated:
SeaSpine Inc.
SeaSpine Inc. is a Carlsbad, California-based medical device company focused on spinal implants and orthobiologics for fusion surgery.
SeaSpine Inc.
SeaSpine Inc. was established as a standalone entity following a 2015 spin-off from Integra LifeSciences Holdings Corporation. The firm designs, manufactures, and distributes surgical implants and biologic materials used in spinal fusion surgeries. Its product lines include the WaveForm family of interbody fusion devices and the Mariner line of fixation systems. The company sells directly to hospitals and ambulatory surgical centers in the United States and through distributors in Europe, Latin America, and parts of Asia. SeaSpine reported revenue of approximately $65 million for the fiscal year 2022 (per the firm's 10-K filing). It competes with larger orthopedic firms such as Medtronic and Johnson & Johnson in the spinal implant market. As of its most recent public filings, SeaSpine employed roughly 260 people and operated from a single headquarters in Carlsbad, California. The firm maintains a research-and-development facility focused on biologic processing and implant testing. It does not manage third-party capital or operate as a traditional investment vehicle. SeaSpine is structured as a publicly traded corporation (Nasdaq: SPNE) with no family-office or wealth-management affiliation. Its governance follows conventional corporate board oversight and executive management, distinct from the single-family-office model. This public-market structure provides transparency through quarterly earnings reports and SEC disclosures.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Carlsbad
Corporate office
Carlsbad, CA, United States
Frequently asked questions
Does SeaSpine Inc. manage third-party capital or operate as a family office?
No. SeaSpine is a publicly traded medical device company (Nasdaq: SPNE) that designs and sells spinal surgery products. It does not manage external capital, private wealth, or investment funds.
What is SeaSpine's core product focus?
SeaSpine focuses on spinal fusion hardware and biologic materials. Its product range includes interbody fusion devices like the WaveForm series, fixation systems such as Mariner, and orthobiologic grafts derived from cortical bone.
Who are SeaSpine's primary customers?
SeaSpine sells directly to U.S. hospitals and ambulatory surgical centers. Outside the United States, it distributes through regional partners in Europe, Latin America, and select Asian markets (per the firm's 10-K).
Is SeaSpine related to Integra LifeSciences?
SeaSpine was spun off from Integra LifeSciences in 2015 as an independent public company. There is no ongoing operational or ownership relationship between the two firms.
What is SeaSpine's public-trading status?
SeaSpine trades on the Nasdaq exchange under the ticker symbol SPNE. Its financial performance is disclosed in quarterly earnings reports and annual 10-K filings.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: